The Society for Clinical Research Sites (SCRS) honors DM Clinical Research with the SPRIA Award for innovation in patient recruitment at the Site Solutions Summit. [more...]

Enrollment concludes in a Type 2 Diabetes Insulin study at Dr Patel’s site in Houston.  38 subjects enrolled against a sponsor goal of 10!

Ongoing enrollment in an angina study in Tomball: so far 24 patients successfully enrolled—goal was 6.

Type 2 Diabetes study at Dr Valika’s Chicago site: sponsor goal was 6; 11 enrolled and recruitment continues.
Staff Resources
"We are the first Chinese Pharmaceutical company to conduct phase 2 clinical trials for a botanical drug product in the USA. We found DM Clinical Research, SMO, on the Internet. To my surprise, Mohammad A. Millwala, the CEO, and Syed, the Managing Director of DM were immediately engaged in our project, read through our protocols, and very professionally started the site identification process. DM is the one who enrolled the very first patient for our study and has the most patients randomized and completed so far, out of all of our 7 clinical sites! Over the year, the work of DM maintained its commitment to its clients: to provide good start up speed, credible research quality, and uninterrupted site-sponsor communications. I highly recommend DM to other pharmaceutical companies, especially to pharmaceutical companies who are conducting clinical research for alternative therapies."
Henry Sun, PhD. CBS